Cargando…
Increasing Specificity of Targeted DNA Methylation Editing by Non-Enzymatic CRISPR/dCas9-Based Steric Hindrance
As advances in genome engineering inch the technology towards wider clinical use—slowed by technical and ethical hurdles—a newer offshoot, termed “epigenome engineering”, offers the ability to correct disease-causing changes in the DNA without changing its sequence and, thus, without some of the unf...
Autores principales: | Sapozhnikov, Daniel M., Szyf, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215309/ https://www.ncbi.nlm.nih.gov/pubmed/37238909 http://dx.doi.org/10.3390/biomedicines11051238 |
Ejemplares similares
-
Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9
por: Sapozhnikov, Daniel M., et al.
Publicado: (2021) -
The PROTECTOR strategy employs dCas orthologs to sterically shield off-target sites from CRISPR/Cas activity
por: Sapozhnikov, Daniel M., et al.
Publicado: (2023) -
CRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and shapes immune progeny
por: Saunderson, Emily A., et al.
Publicado: (2023) -
Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing
por: Hanzawa, Nozomi, et al.
Publicado: (2020) -
CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing
por: Moradpour, Mahdi, et al.
Publicado: (2019)